Perspective Therapeutics Quote - CATX

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

9.97

Bid

Ask

Volume

2,725,185

9.495 Day's Range 10.15

2.05 52 Week Range 19.05

Market Cap

669.742M

Previous Close

9.87

Open

9.83

Last Trade

5223714

9.97

Last Trade Time

Financial Volume

US$ 26,464,662

VWAP

9.7111

Average Volume (3m)

5,763,987

Shares Outstanding

67,378,432

Dividend Yield

PE Ratio

-14.40

Earnings Per Share (EPS)

-0.69

Revenue

1.43M

Net Profit

-46.51M

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company¿s melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more

Sector

Eating Places

Industry

Surgical,med Instr,apparatus

Website

perspectivetherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1983

Perspective Therapeutics Inc is listed in the Eating Places sector of the American Stock Exchange with ticker CATX. The last closing price for Perspective Therapeutics was US$9.87. Over the last year, Perspective Therapeutics shares have traded in a share price range of US$ 2.05 to US$ 19.05.

Perspective Therapeutics currently has 67,378,432 shares outstanding. The market capitalization of Perspective Therapeutics is US$669.74 million. Perspective Therapeutics has a price to earnings ratio (PE ratio) of -14.40.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.51	-4.86641221374	10.48	10.76	8.16	1208113	9.78234086	CS
4	-3.93	-28.273381295	13.9	15.2	8.16	4640848	12.55937526	CS
12	-4.53	-31.2413793103	14.5	19.05	8.16	5763987	14.82188241	CS
26	4.99	100.200803213	4.98	19.05	3.799	4243434	12.81352908	CS
52	3.57	55.78125	6.4	19.05	2.05	2449874	11.48583169	CS
156	6.207	164.948179644	3.763	19.05	2.05	1957883	11.06531021	CS
260	6.207	164.948179644	3.763	19.05	2.05	1957883	11.06531021	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DNDelta 9 Cannabis Inc	$ 0.015 (50.00%)	1.1M
BRMIBoat Rocker Media Inc	$ 1.02 (29.11%)	1.84M
TSATTelesat Corporation	$ 12.50 (17.26%)	3.24k
QECQuesterre Energy Corporation	$ 0.25 (16.28%)	24.6k
GEOGeodrill Limited	$ 2.30 (15.58%)	47.28k
NCPNickel Creek Platinum Corp	$ 0.01 (-33.33%)	1.07k
LPENLoop Energy Inc	$ 0.025 (-28.57%)	73.62k
ASNDAscendant Resources Inc	$ 0.035 (-22.22%)	1,000
FLNTFlint Corporation	$ 0.025 (-16.67%)	16.5k
BNGBengal Energy Ltd	$ 0.03 (-14.29%)	85k
TRPTC Energy Corporation	$ 51.87 (-1.76%)	34.35M
BNSBank of Nova Scotia	$ 62.58 (0.29%)	18.9M
POWPower Corp of Canada	$ 38.02 (-1.66%)	13.19M
TDToronto Dominion Bank	$ 75.20 (0.09%)	9.87M
MFCManulife Financial Corporation	$ 36.44 (0.41%)	6.48M